| abstract |
The present invention provides: a labelled beta -amyloid peptide or active fragment; a composition including the labelled beta -amyloid peptide or active fragment thereof and a pharmaceutical carrier; a method for identifying active fragments of beta -amyloid peptide; a method for labelling the beta -amyloid peptide or an active fragment thereof; methods of using the labelled peptide or peptide fragment for detecting or monitoring Alzheimer's disease in a patient; and methods for screening agents that enhance or inhibit beta -amyloid aggregation or deposition onto tissue or other amyloid substance, such as silk. |